AAOS 2024: One- Vs Two-Stage Treatment for Periprosthetic Joint Infection: Interim Results .
One-stage versus two-stage treatment for prosthetic joint infection: a prospective, randomized clinical trial
321 patients with chronically infected hip and knee arthroplasties were randomized to receive either a one-stage (n=164) or two-stage treatment (n=157). Outcomes of interest included a one-year success rate, relative risk of failure, and adverse events. Interim results indicated that adverse events, one-year success rate, and relative risk were similar between the two groups.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!
0 of 4 monthly FREE articles unlocked
